siRNAs targeting multidrug transporter genes sensitise breast tumour to doxorubicin in a syngeneic mouse model
- 11 February 2019
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 27 (3) , 325-337
Abstract
Chemotherapy, the commonly favored approach to treat cancer is frequently associated with treatment failure and recurrence of disease as a result of development of multidrug resistance (MDR) with concomitant over-expression of drug efflux proteins on cancer cells. One of the most widely used drugs, doxorubicin (Dox) is a substrate of three different ATP-binding cassette (ABC) transporters, namely, ABCB1, ABCG2 and ABCC1, predominantly contributing to MDR phenotype in cancer. To silence these transporter-coding genes and thus enhance the therapeutic efficacy of Dox, pH-sensitive carbonate apatite (CA) nanoparticles (NPs) were employed as a carrier system to co-deliver siRNAs against these genes and Dox in breast cancer cells and in a syngeneic breast cancer mouse model. siRNAs and Dox were complexed with NPs by incubation at 37°C and used to treat cancer cell lines to check cell viability and caspase-mediated signal. 4T1 cells induced breast cancer mouse model was used for treatment with the complex to confirm their action in tumour regression. Smaller (∼ 200 nm) and less polydisperse NPs that were taken up more effectively by tumor tissue could enhance Dox chemosensitivity, significantly reducing the tumor size in a very low dose of Dox (0.34 mg/Kg), in contrast to the limited effect observed in breast cancer cell lines. The study thus proposes that simultaneous delivery of siRNAs against transporter genes and doxorubicin with the help of CA NPs could be a potential therapeutic intervention in effectively treating MDR breast cancer.Keywords
Funding Information
- Ministry of Higher Education
This publication has 61 references indexed in Scilit:
- Fabrication and Intracellular Delivery of Doxorubicin/Carbonate Apatite Nanocomposites: Effect on Growth Retardation of Established Colon TumorPLOS ONE, 2013
- Forced Expression of Heat Shock Protein 27 (Hsp27) Reverses P-Glycoprotein (ABCB1)-mediated Drug Efflux and MDR1 Gene Expression in Adriamycin-resistant Human Breast Cancer CellsJournal of Biological Chemistry, 2011
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transportersCell Death & Disease, 2011
- Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer ModelThe American Journal of Pathology, 2011
- Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAsNature Biotechnology, 2009
- Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cellsNucleic Acids Research, 2007
- Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISCNucleic Acids Research, 2007
- Competition for RISC binding predicts in vitro potency of siRNANucleic Acids Research, 2006
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002